Company intelligence / Profile preview

Phytronix

Quebec City / Québec City, Quebec, Canadaphytronix.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Phytronix has commercialized its patented LDTD® technology and the Luxon Ion Source®, enabling ultra-high-throughput mass spectrometry analysis with sample processing times under four seconds. Their products are widely adopted in pharmaceutical, toxicology, clinical diagnostics, and environmental testing laboratories for rapid quantitation without chromatography.[3][5] No clinical drug results as they do not develop therapeutics.

Therapeutic areas: Other
Modalities: Device (analytical instrumentation for mass spectrometry)
Industry: Drug Discovery Services

Partnerships

MEDTEQ+ consortium partnership on medical technology innovation support [3]

Beyond the preview

Go deeper on Phytronix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytronix.

Explore the full profile